These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [H1 and H2 histamine antagonists. Principles and rules of use]. Perault MC; Vandel B Rev Prat; 1996 Jun; 46(12):1547-50. PubMed ID: 8881170 [No Abstract] [Full Text] [Related]
6. [The effects of an H2 receptor antagonist (cimetidine) in asthmatic patients]. Kobayashi H; Adachi M; Takahashi T Arerugi; 1985 Jan; 34(1):23-32. PubMed ID: 2859846 [No Abstract] [Full Text] [Related]
7. [Experimental study of Dolispan in the therapy of peptic ulcer]. Manolov P; Todorov S Eksp Med Morfol; 1974; 13(1):36-9. PubMed ID: 4151718 [No Abstract] [Full Text] [Related]
8. The medical therapy of peptic ulcer. Bevan G Postgrad Med J; 1975; 51(5 Suppl):14-8. PubMed ID: 7780 [No Abstract] [Full Text] [Related]
9. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
10. [Clinical and radiographical study on the effects of the treatment of peptic ulcer with a new antacid-antiulcer agent]. Piro E; Florio F; Tripodi R Clin Ter; 1970 May; 53(4):323-48. PubMed ID: 4394193 [No Abstract] [Full Text] [Related]
11. [Treatment of ulcer with a new antacid-antisecretive-antispastic combination]. Castellazzi V; Marenco G; Ghibaudi D Clin Ter; 1969 Apr; 49(1):47-61. PubMed ID: 4396961 [No Abstract] [Full Text] [Related]
12. [Indications and successes of conservative therapy in gastroenterology: peptic ulcer]. Gugler R Z Gastroenterol Verh; 1989 Jul; 24():82-4. PubMed ID: 2474995 [No Abstract] [Full Text] [Related]
13. [Therapeutic effect of a new antisecretory and anti-acid drug]. Galli L; Bissi A Rev Bras Gastroenterol; 1967; 19(3):43-9. PubMed ID: 4387428 [No Abstract] [Full Text] [Related]
14. [Long-term prevention with H2 receptor antagonists. An effective concept for treating ulcer disease]. Stöppel G; Rösch W Versicherungsmedizin; 1991 Dec; 43(6):176-80. PubMed ID: 1686689 [TBL] [Abstract][Full Text] [Related]
15. [New views on the physiopathology of peptic ulcer]. Ottenjann R MMW Munch Med Wochenschr; 1974 Feb; 116(5):181-4. PubMed ID: 4149847 [No Abstract] [Full Text] [Related]
16. [Long-term therapy of gastroduodenal ulcer disease]. Hahn L Z Arztl Fortbild (Jena); 1993; Suppl 1():1-3. PubMed ID: 7901947 [No Abstract] [Full Text] [Related]
17. [The status of H2-blocker therapy today]. Rameis H Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029 [TBL] [Abstract][Full Text] [Related]
18. [Histamine as the principal pathogenetic factor in gastroduodenal ulcer. Research priorities]. Businco L Minerva Med; 1980 Sep; 71(31):2193-7. PubMed ID: 6158718 [TBL] [Abstract][Full Text] [Related]
19. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment]. Peitsch W Zentralbl Chir; 1986; 111(23):1433-40. PubMed ID: 2881413 [TBL] [Abstract][Full Text] [Related]